Mucosal Tissue Injury in Cancer Therapy. More Than Mucositis and Mouthwash
- 1 July 2002
- journal article
- review article
- Published by Wiley in Cancer Practice
- Vol. 10 (4) , 179-191
- https://doi.org/10.1046/j.1523-5394.2002.104009.x
Abstract
The purpose of this article is as follows: 1) to describe the characteristics and scope of mucosal tissue injury associated with cancer treatment; 2) to discuss recent advances in related basic and clinical science; and 3) to articulate research needs and opportunities to be addressed through collaborative interdisciplinary research. Mucosal tissue injury is both a direct and indirect consequence of cancer therapy, with manifestations that include damage and a number of other potentially serious sequelae. Current research in mucosal tissue injury is focused on the biology, immunology, and genetics of mucosal injury; clinical problems; assessment and management; and processes and outcomes of care. Results from these various areas of research enhance the understanding of the mechanisms of mucosal tissue injury, provide direction for the development of policy and for clinical practice, and help to define research needs and opportunities. Future research on the complex process of mucosal tissue injury will be interdisciplinary and will cross the boundaries among basic, translational, and clinical science.Keywords
This publication has 56 references indexed in Scilit:
- Factors Influencing Oral Mucositis in Patients Receiving ChemotherapyCancer Practice, 2000
- Oral problems in supportive care: no longer an orphan topic?Supportive Care in Cancer, 2000
- Mapping dynamic epithelial cell proliferative activity within the oral cavity of man: a new insight into carcinogenesis?British Journal of Oral and Maxillofacial Surgery, 1999
- Circadian Variation in the Expression of Cell-Cycle Proteins in Human Oral EpitheliumThe American Journal of Pathology, 1999
- Role of Epidermal Growth Factor (EGF) in Oesophageal Mucosal IntegrityCurrent Medical Research and Opinion, 1998
- Keratinocytes and Cytokine/Growth FactorsCritical Reviews in Oral Biology & Medicine, 1996
- Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk FactorsClinical Infectious Diseases, 1994
- Biophysical kinetic modeling of buccal absorptionAdvanced Drug Delivery Reviews, 1993
- Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing FactorsClinical Infectious Diseases, 1992
- Viridans streptococcal bacteraemia in patients with haematological and solid malignanciesEuropean Journal of Cancer and Clinical Oncology, 1991